<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ketendo</journal-id><journal-title-group><journal-title xml:lang="ru">Клиническая и экспериментальная тиреоидология</journal-title><trans-title-group xml:lang="en"><trans-title>Clinical and experimental thyroidology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-5472</issn><issn pub-type="epub">2310-3787</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/ket2017320-28</article-id><article-id custom-type="elpub" pub-id-type="custom">ketendo-9397</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Обзоры литературы</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Review of literature</subject></subj-group></article-categories><title-group><article-title>Новые возможности в диагностике эндокринной офтальмопатии (обзор литературы)</article-title><trans-title-group xml:lang="en"><trans-title>New opportunities in endocrine ophthalmopathy diagnostics (review)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6223-8888</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Таскина</surname><given-names>Елизавета Сергеевна</given-names></name><name name-style="western" xml:lang="en"><surname>Taskina</surname><given-names>Elizaveta S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант кафедры офтальмологии</p></bio><bio xml:lang="en"><p>MD</p></bio><email xlink:type="simple">taskins@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8899-5465</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Харинцева</surname><given-names>Светалана Владимировна</given-names></name><name name-style="western" xml:lang="en"><surname>Charinzeva</surname><given-names>Svetlana V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, профессор, заведующая кафедрой офтальмологии</p></bio><bio xml:lang="en"><p>MD, PhD, Professor</p></bio><email xlink:type="simple">s.v.19.28@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4681-585X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Харинцев</surname><given-names>Владимир Вячеславович</given-names></name><name name-style="western" xml:lang="en"><surname>Charinzev</surname><given-names>Vladimir V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант кафедры нормальная физиология</p></bio><bio xml:lang="en"><p>MD</p></bio><email xlink:type="simple">tevton-aberhard@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6823-9523</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Серкин</surname><given-names>Дмитрий Михайлович</given-names></name><name name-style="western" xml:lang="en"><surname>Serkin</surname><given-names>Dmitriy M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, доцент кафедры госпитальной терапии и эндокринологии</p></bio><bio xml:lang="en"><p>MD, PhD</p></bio><email xlink:type="simple">serkind@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>&lt;p&gt;ФГБОУ ВО Читинская государственная медицинская академия&lt;/p&gt;</institution><country>Россия</country></aff><aff xml:lang="en"><institution>&lt;p&gt;Chita State Medical Academy&lt;/p&gt;</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>15</day><month>12</month><year>2017</year></pub-date><volume>13</volume><issue>3</issue><fpage>20</fpage><lpage>28</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Таскина Е.С., Харинцева С.В., Харинцев В.В., Серкин Д.М., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Таскина Е.С., Харинцева С.В., Харинцев В.В., Серкин Д.М.</copyright-holder><copyright-holder xml:lang="en">Taskina E.S., Charinzeva S.V., Charinzev V.V., Serkin D.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.cet-endojournals.ru/jour/article/view/9397">https://www.cet-endojournals.ru/jour/article/view/9397</self-uri><abstract><p>Эндокринная офтальмопатия (ЭОП) – это прогрессирующее аутоиммунное заболевание, поражающее ретробульбарные мягкие ткани на фоне заболеваний щитовидной железы. Представлена статистическая информация по данному заболеванию. В обзоре рассматриваются как общепринятые, так и альтернативные подходы к диагностике разных стадий ЭОП. Дана подробная клиническая симптоматика, основные классификации определения степени тяжести и активности ЭОП, необходимый перечень физикальных и инструментальных обследований. Описана диагностическая ценность компьютерной томографии, магнитно-резонансной томографии, оптической когерентной томографии, Гейдельбергской ретинальной томографии, радиоизотопных исследований, триплексного сканирования магистральных сосудов глаза, метода доплеровского картирования, индоцианин-зеленой ангиографии, а также гистологического исследования биоптатов мягких ретробульбарных тканей при ЭОП. Общепринятые методы диагностики ЭОП имеют свои недостатки. Поэтому в настоящее время перспективным направлением являются иммунологические, биохимические и генетические исследования маркеров активности ЭОП. Особенностью данных методов в диагностике ЭОП является точность, возможность многократного измерения, минимум побочных эффектов, а также относительно низкая стоимость. Отмечена важность дальнейшего изучения ключевых механизмов развития отека, лейкоцитарной инфильтрации с последующим формированием фиброза экстраокулярных мышц и ретробульбарной клетчатки при ЭОП, что, возможно, сможет улучшить диагностику в клинически сложных случаях и при начальных стадиях заболевания.</p></abstract><trans-abstract xml:lang="en"><p>Endocrine ophthalmopathy (EOP) is a progressive autoimmune disease that affects soft retrobulbar tissues in thyroid gland diseases. The statistical data on this disease are presented. The review presents both generally accepted and alternative approaches to the diagnosis of EOP different stages. Detailed clinical symptoms, main severity and activity score classifications of EOP, the required list of physical and instrumental examinations are given. We described the diagnostic value of computed tomography, magnetic resonance imaging, optical coherence tomography, Heidelberg Retina Tomography, radioisotope studies, triplex scanning of the major vessels of the eye, the Doppler mapping method, indocyanine-green angiography, as well as the histological examination of soft retrobulbar tissues biopsy in EOP. Generally accepted diagnostic methods of EOP have their disadvantages. Therefore, nowadays the promising direction is immunological, biochemical and genetic studies of EOP activity markers. The peculiarity of these methods in EOP diagnosis is an accuracy, possibility of multiple measurements, few side effects and a relatively low cost. Further studies of key mechanisms of the development of edema, leukocyte infiltration with subsequent formation of fibrosis of extraocular muscles and retrobulbar fiber in EOP is of significance, which may improve diagnostics of clinical complicated cases and initial stages of the disease.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Эндокринная офтальмопатия</kwd><kwd>глазодвигательные мышцы</kwd><kwd>ретробульбарная клетчатка</kwd><kwd>диагностика</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Thyroid eye disease</kwd><kwd>endocrine ophthalmopathy</kwd><kwd>Graves’ ophthalmopathy</kwd><kwd>extraocular muscles</kwd><kwd>retrobulbar tissue</kwd><kwd>diagnostics</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бровкина А.Ф. Эндокринная офтальмопатия. — М.: ГЭОТАР-Медиа; 2008. [Brovkina AF. Endokrinnaya oftal’mopatiya. Moscow: GEOTAR-Media; 2008. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Бровкина А.Ф. Эндокринная офтальмопатия. — М.: ГЭОТАР-Медиа; 2008. [Brovkina AF. Endokrinnaya oftal’mopatiya. Moscow: GEOTAR-Media; 2008. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И.И., Мельниченко Г.А., Свириденко Н.Ю., и др. Федеральные клинические рекомендации по диагностике и лечению эндокринной офтальмопатии при аутоиммунной патологии щитовидной железы. // Проблемы эндокринологии. — 2015. — Т. 61. — №1. — С. 61–74. [Dedov II, Melnichenko GA, Sviridenko NY, et al. Federal clinical recommendations on diagnostics and treatment of endocrine ophthalmopathy associated with autoimmune thyroid pathology. Problems of Endocrinology. 2015;61(1):61-74. (In Russ.)] doi: 10.14341/probl201561161-74</mixed-citation><mixed-citation xml:lang="en">Дедов И.И., Мельниченко Г.А., Свириденко Н.Ю., и др. Федеральные клинические рекомендации по диагностике и лечению эндокринной офтальмопатии при аутоиммунной патологии щитовидной железы. // Проблемы эндокринологии. — 2015. — Т. 61. — №1. — С. 61–74. [Dedov II, Melnichenko GA, Sviridenko NY, et al. Federal clinical recommendations on diagnostics and treatment of endocrine ophthalmopathy associated with autoimmune thyroid pathology. Problems of Endocrinology. 2015;61(1):61-74. (In Russ.)] doi: 10.14341/probl201561161-74</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Петунина Н.А., Трухина Л.В., Мартиросян Н.С. Эндокринная офтальмопатия: современный взгляд. // Проблемы эндокринологии. — 2012. — Т. 58. — №6. — C. 24–32. [Petunina NA, Trukhina LV, Martirosyan NS. Endocrine ophthalmopathy: state-of-the-art approaches. Problems of Endocrinology. 2012;58(6):24-32. (In Russ.)] doi: 10.14341/probl201258624-32</mixed-citation><mixed-citation xml:lang="en">Петунина Н.А., Трухина Л.В., Мартиросян Н.С. Эндокринная офтальмопатия: современный взгляд. // Проблемы эндокринологии. — 2012. — Т. 58. — №6. — C. 24–32. [Petunina NA, Trukhina LV, Martirosyan NS. Endocrine ophthalmopathy: state-of-the-art approaches. Problems of Endocrinology. 2012;58(6):24-32. (In Russ.)] doi: 10.14341/probl201258624-32</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Исмаилова Д.С., Подгорная Н.Н. Поражение роговицы при эндокринной офтальмопатии. // Вестник офтальмологии. — 2015. — Т. 131. — №5. — C. 98-103. [Ismailova DS, Podgornaya NN. Corneal damage in patients with thyroid eye disease. Annals of ophthalmology. 2015;131(5):98-103. (In Russ.)] doi: 10.17116/oftalma2015131598-103</mixed-citation><mixed-citation xml:lang="en">Исмаилова Д.С., Подгорная Н.Н. Поражение роговицы при эндокринной офтальмопатии. // Вестник офтальмологии. — 2015. — Т. 131. — №5. — C. 98-103. [Ismailova DS, Podgornaya NN. Corneal damage in patients with thyroid eye disease. Annals of ophthalmology. 2015;131(5):98-103. (In Russ.)] doi: 10.17116/oftalma2015131598-103</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Sahli E, Gunduz K. Thyroid-associated Ophthalmopathy. Turk J Ophthalmol. 2017;47(2):94-105. doi: 10.4274/tjo.80688</mixed-citation><mixed-citation xml:lang="en">Sahli E, Gunduz K. Thyroid-associated Ophthalmopathy. Turk J Ophthalmol. 2017;47(2):94-105. doi: 10.4274/tjo.80688</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Salvi M, Campi I. Medical Treatment of Graves' Orbitopathy. Horm Metab Res. 2015;47(10):779-788. doi: 10.1055/s-0035-1554721</mixed-citation><mixed-citation xml:lang="en">Salvi M, Campi I. Medical Treatment of Graves' Orbitopathy. Horm Metab Res. 2015;47(10):779-788. doi: 10.1055/s-0035-1554721</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Bahn RS. Current Insights into the Pathogenesis of Graves' Ophthalmopathy. Horm Metab Res. 2015;47(10):773-778. doi: 10.1055/s-0035-1555762</mixed-citation><mixed-citation xml:lang="en">Bahn RS. Current Insights into the Pathogenesis of Graves' Ophthalmopathy. Horm Metab Res. 2015;47(10):773-778. doi: 10.1055/s-0035-1555762</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Konuk O, Onaran Z, Ozhan Oktar S, et al. Intraocular pressure and superior ophthalmic vein blood flow velocity in Graves' orbitopathy: relation with the clinical features. Graefes Arch Clin Exp Ophthalmol. 2009;247(11):1555-1559. doi: 10.1007/s00417-009-1144-0</mixed-citation><mixed-citation xml:lang="en">Konuk O, Onaran Z, Ozhan Oktar S, et al. Intraocular pressure and superior ophthalmic vein blood flow velocity in Graves' orbitopathy: relation with the clinical features. Graefes Arch Clin Exp Ophthalmol. 2009;247(11):1555-1559. doi: 10.1007/s00417-009-1144-0</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lee H, Lee YH, Suh SI, et al. Characterizing Intraorbital Optic Nerve Changes on Diffusion Tensor Imaging in Thyroid Eye Disease Before Dysthyroid Optic Neuropathy. J Comput Assist Tomogr. 2017. doi: 10.1097/RCT.0000000000000680</mixed-citation><mixed-citation xml:lang="en">Lee H, Lee YH, Suh SI, et al. Characterizing Intraorbital Optic Nerve Changes on Diffusion Tensor Imaging in Thyroid Eye Disease Before Dysthyroid Optic Neuropathy. J Comput Assist Tomogr. 2017. doi: 10.1097/RCT.0000000000000680</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Holds JB, Chang WJ, Durairaj VD, et al. Orbital inflammatory and infectious disorders: thyroid eye disease. In: American Academy of Ophthalmology. Basic and clinical science course: Orbit, eyelids, and lacrimal system. San-Francisco: American Academy of Ophthalmology. 2013:47-55.</mixed-citation><mixed-citation xml:lang="en">Holds JB, Chang WJ, Durairaj VD, et al. Orbital inflammatory and infectious disorders: thyroid eye disease. In: American Academy of Ophthalmology. Basic and clinical science course: Orbit, eyelids, and lacrimal system. San-Francisco: American Academy of Ophthalmology. 2013:47-55.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Bartalena L, Baldeschi L, Boboridis K, et al. The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy. Eur Thyroid J. 2016;5(1):9-26. doi: 10.1159/000443828</mixed-citation><mixed-citation xml:lang="en">Bartalena L, Baldeschi L, Boboridis K, et al. The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy. Eur Thyroid J. 2016;5(1):9-26. doi: 10.1159/000443828</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Menconi F, Marcocci C, Marino M. Diagnosis and classification of Graves' disease. Autoimmun Rev. 2014;13(4-5):398-402. doi: 10.1016/j.autrev.2014.01.013</mixed-citation><mixed-citation xml:lang="en">Menconi F, Marcocci C, Marino M. Diagnosis and classification of Graves' disease. Autoimmun Rev. 2014;13(4-5):398-402. doi: 10.1016/j.autrev.2014.01.013</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Серкин Д.М., Серебрякова О.В., Просяник В.И. Клиническая характеристика эндокринной офтальмопатии в Забайкалье. // Вестник Новосибирского государственного университета. Серия: Биология, клиническая медицина. — 2011. — Т. 9. — №1. — С. 168-171. [Serkin DM, Serebryakova OV, Prosyanik VI. Clinical сharacteristic of Graves' orbitopathy in region Vestnik Novosibirskogo gosudarstvennogo universiteta. Seriia biologiia, klinicheskaia meditsina. 2011;9(1):168-171. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Серкин Д.М., Серебрякова О.В., Просяник В.И. Клиническая характеристика эндокринной офтальмопатии в Забайкалье. // Вестник Новосибирского государственного университета. Серия: Биология, клиническая медицина. — 2011. — Т. 9. — №1. — С. 168-171. [Serkin DM, Serebryakova OV, Prosyanik VI. Clinical сharacteristic of Graves' orbitopathy in region Vestnik Novosibirskogo gosudarstvennogo universiteta. Seriia biologiia, klinicheskaia meditsina. 2011;9(1):168-171. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Бровкина А.Ф., Яценко О.Ю. О целесообразности выделения клинической формы липогенного варианта отечного экзофтальма. // Вестник офтальмологии. — 2013. — Т. 129. — №2. — C. 28-32. [Brovkina AF, Yatsenko OY. Rationale for distinguishing the lipogenic form of thyroid orbitopath. Annals of ophthalmology. 2013;129(2):28-32. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Бровкина А.Ф., Яценко О.Ю. О целесообразности выделения клинической формы липогенного варианта отечного экзофтальма. // Вестник офтальмологии. — 2013. — Т. 129. — №2. — C. 28-32. [Brovkina AF, Yatsenko OY. Rationale for distinguishing the lipogenic form of thyroid orbitopath. Annals of ophthalmology. 2013;129(2):28-32. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Wiersinga WM, Prummel MF, Terwee CB. Effects of Graves' ophthalmopathy on quality of life. J Endocrinol Invest. 2004;27(3):259-264. doi: 10.1007/BF03345275</mixed-citation><mixed-citation xml:lang="en">Wiersinga WM, Prummel MF, Terwee CB. Effects of Graves' ophthalmopathy on quality of life. J Endocrinol Invest. 2004;27(3):259-264. doi: 10.1007/BF03345275</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Dagi LR, Zoumalan CI, Konrad H, et al. Correlation between extraocular muscle size and motility restriction in thyroid eye disease. Ophthal Plast Reconstr Surg. 2011;27(2):102-110. doi: 10.1097/IOP.0b013e3181e9a063</mixed-citation><mixed-citation xml:lang="en">Dagi LR, Zoumalan CI, Konrad H, et al. Correlation between extraocular muscle size and motility restriction in thyroid eye disease. Ophthal Plast Reconstr Surg. 2011;27(2):102-110. doi: 10.1097/IOP.0b013e3181e9a063</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Cеркин Д.М., Серебрякова О.В., Просяник В.И., и др. Рентгенологическая характеристика эндокринной офтальмопатии в условиях Забайкалья. Кубанский научный медицинский вестник. — 2011. — №1. — C. 145-148. [Sherkin DM, Serebryakova OV, Prosyanik VI, et al. X-ray characteristic of Graves orbitopathy in region Zabaykalye. Kubanskii nauchnyii meditsinskii vestnik. 2011;(1):145-148. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Cеркин Д.М., Серебрякова О.В., Просяник В.И., и др. Рентгенологическая характеристика эндокринной офтальмопатии в условиях Забайкалья. Кубанский научный медицинский вестник. — 2011. — №1. — C. 145-148. [Sherkin DM, Serebryakova OV, Prosyanik VI, et al. X-ray characteristic of Graves orbitopathy in region Zabaykalye. Kubanskii nauchnyii meditsinskii vestnik. 2011;(1):145-148. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Gonçalves ACP, Gebrim EM, Monteiro ML. Imaging studies for diagnosing Graves' orbitopathy and dysthyroid optic neuropathy. Clinics. 2012;67(11):1327-1334. doi: 10.6061/clinics/2012(11)18</mixed-citation><mixed-citation xml:lang="en">Gonçalves ACP, Gebrim EM, Monteiro ML. Imaging studies for diagnosing Graves' orbitopathy and dysthyroid optic neuropathy. Clinics. 2012;67(11):1327-1334. doi: 10.6061/clinics/2012(11)18</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Lee JY, Bae K, Park KA, et al. Correlation between Extraocular Muscle Size Measured by Computed Tomography and the Vertical Angle of Deviation in Thyroid Eye Disease. PLoS One. 2016;11(1):e0148167. doi: 10.1371/journal.pone.0148167</mixed-citation><mixed-citation xml:lang="en">Lee JY, Bae K, Park KA, et al. Correlation between Extraocular Muscle Size Measured by Computed Tomography and the Vertical Angle of Deviation in Thyroid Eye Disease. PLoS One. 2016;11(1):e0148167. doi: 10.1371/journal.pone.0148167</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Чепурина А.А., Свириденко Н.Ю., Ремизов О.В., и др. Клинико-томографические взаимоотношения при диплопии у пациентов с эндокринной офтальмопатией и болезнью Грейвса. // Клиническая и экспериментальная тиреоидология. — 2012. — Т. 8. — №1. — С. 40-45. [Chepurina AA, Sviridenko NY, Remizov OV, et al. The clinical tomographic interconnection in diplopia of patients with Graves' orbitopathy. Clinical and experimental thyroidology. 2012;8(1):40-45. (In Russ.)] doi: 10.14341/ket20128140-45</mixed-citation><mixed-citation xml:lang="en">Чепурина А.А., Свириденко Н.Ю., Ремизов О.В., и др. Клинико-томографические взаимоотношения при диплопии у пациентов с эндокринной офтальмопатией и болезнью Грейвса. // Клиническая и экспериментальная тиреоидология. — 2012. — Т. 8. — №1. — С. 40-45. [Chepurina AA, Sviridenko NY, Remizov OV, et al. The clinical tomographic interconnection in diplopia of patients with Graves' orbitopathy. Clinical and experimental thyroidology. 2012;8(1):40-45. (In Russ.)] doi: 10.14341/ket20128140-45</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Tachibana S, Murakami T, Noguchi H, et al. Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves’ ophthalmopathy. Endocrine J. 2010;57(10):853-861. doi: 10.1507/endocrj.K10E-156</mixed-citation><mixed-citation xml:lang="en">Tachibana S, Murakami T, Noguchi H, et al. Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves’ ophthalmopathy. Endocrine J. 2010;57(10):853-861. doi: 10.1507/endocrj.K10E-156</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Rabinowitz MP, Carrasco JR. Update on advanced imaging options for thyroid-associated orbitopathy. Saudi J Ophthalmol. 2012;26(4):385-392. doi: 10.1016/j.sjopt.2012.07.006</mixed-citation><mixed-citation xml:lang="en">Rabinowitz MP, Carrasco JR. Update on advanced imaging options for thyroid-associated orbitopathy. Saudi J Ophthalmol. 2012;26(4):385-392. doi: 10.1016/j.sjopt.2012.07.006</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Fallon M, Valero O, Pazos M, Anton A. Diagnostic accuracy of imaging devices in glaucoma: A meta-analysis. Surv Ophthalmol. 2017;62(4):446-461. doi: 10.1016/j.survophthal.2017.01.001</mixed-citation><mixed-citation xml:lang="en">Fallon M, Valero O, Pazos M, Anton A. Diagnostic accuracy of imaging devices in glaucoma: A meta-analysis. Surv Ophthalmol. 2017;62(4):446-461. doi: 10.1016/j.survophthal.2017.01.001</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Park KA, Kim YD, In Woo K, et al. Optical coherence tomography measurements in compressive optic neuropathy associated with dysthyroid orbitopathy. Graefes Arch Clin Exp Ophthalmol. 2016;254(8):1617-1624. doi: 10.1007/s00417-016-3335-9</mixed-citation><mixed-citation xml:lang="en">Park KA, Kim YD, In Woo K, et al. Optical coherence tomography measurements in compressive optic neuropathy associated with dysthyroid orbitopathy. Graefes Arch Clin Exp Ophthalmol. 2016;254(8):1617-1624. doi: 10.1007/s00417-016-3335-9</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Yang B, Ye C, Yu M, et al. Optic disc imaging with spectral-domain optical coherence tomography: variability and agreement study with Heidelberg retinal tomograph. Ophthalmology. 2012;119(9):1852-1857. doi: 10.1016/j.ophtha.2012.02.033</mixed-citation><mixed-citation xml:lang="en">Yang B, Ye C, Yu M, et al. Optic disc imaging with spectral-domain optical coherence tomography: variability and agreement study with Heidelberg retinal tomograph. Ophthalmology. 2012;119(9):1852-1857. doi: 10.1016/j.ophtha.2012.02.033</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Michelessi M, Lucenteforte E, Oddone F, et al. Optic nerve head and fibre layer imaging for diagnosing glaucoma. Cochrane Database Syst Rev. 2015(11):CD008803. doi: 10.1002/14651858.CD008803.pub2</mixed-citation><mixed-citation xml:lang="en">Michelessi M, Lucenteforte E, Oddone F, et al. Optic nerve head and fibre layer imaging for diagnosing glaucoma. Cochrane Database Syst Rev. 2015(11):CD008803. doi: 10.1002/14651858.CD008803.pub2</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Харинцева С.В., Серебрякова О.В., Харинцев В.В., Cеркин Д.М. Оптическая когерентная томография в диагностике нейропатии у больных с эндокринной офтальмопатией. // Бюллетень ВСНЦ СО РАМН. — 2011. — №6. — C. 97-99. [Kharintseva SV, Serebryakova OV, Kharintsev VV, Serkin DM. Optic coherent tomography in optic neuropathy diagnostics in patients with endocrine ophthalmopathy. Bull Vost Sib Naucn Sent. 2011;(6):97-99. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Харинцева С.В., Серебрякова О.В., Харинцев В.В., Cеркин Д.М. Оптическая когерентная томография в диагностике нейропатии у больных с эндокринной офтальмопатией. // Бюллетень ВСНЦ СО РАМН. — 2011. — №6. — C. 97-99. [Kharintseva SV, Serebryakova OV, Kharintsev VV, Serkin DM. Optic coherent tomography in optic neuropathy diagnostics in patients with endocrine ophthalmopathy. Bull Vost Sib Naucn Sent. 2011;(6):97-99. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Caliskan S, Acar M, Gurdal C. Choroidal Thickness in Patients with Graves' Ophthalmopathy. Curr Eye Res. 2017;42(3):484-490. doi: 10.1080/02713683.2016.1198488</mixed-citation><mixed-citation xml:lang="en">Caliskan S, Acar M, Gurdal C. Choroidal Thickness in Patients with Graves' Ophthalmopathy. Curr Eye Res. 2017;42(3):484-490. doi: 10.1080/02713683.2016.1198488</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Aguirre-Balsalobre F, Mengual-Verdú E, Muñoz-Acosta JM, et al. Octreotide scintigraphy in thyroid orbitopathy. Arch Soc Esp Oftalmol. 2007;82(3):133-139. doi: 10.4321/s0365-66912007000300004</mixed-citation><mixed-citation xml:lang="en">Aguirre-Balsalobre F, Mengual-Verdú E, Muñoz-Acosta JM, et al. Octreotide scintigraphy in thyroid orbitopathy. Arch Soc Esp Oftalmol. 2007;82(3):133-139. doi: 10.4321/s0365-66912007000300004</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Sun B, Zhang Z, Dong C, et al. (99)Tc(m)-octreotide scintigraphy and serum eye muscle antibodies in evaluation of active thyroid-associated ophthalmopathy. Eye (Lond). 2017;31(5):668-676. doi: 10.1038/eye.2017.42</mixed-citation><mixed-citation xml:lang="en">Sun B, Zhang Z, Dong C, et al. (99)Tc(m)-octreotide scintigraphy and serum eye muscle antibodies in evaluation of active thyroid-associated ophthalmopathy. Eye (Lond). 2017;31(5):668-676. doi: 10.1038/eye.2017.42</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Lopes FP, de Souza SA, Dos Santos Teixeira Pde F, et al. 99mTc-Anti-TNF-alpha scintigraphy: a new perspective within different methods in the diagnostic approach of active Graves ophthalmopathy. Clin Nucl Med. 2012;37(11):1097-1101. doi: 10.1097/RLU.0b013e31826c0c16</mixed-citation><mixed-citation xml:lang="en">Lopes FP, de Souza SA, Dos Santos Teixeira Pde F, et al. 99mTc-Anti-TNF-alpha scintigraphy: a new perspective within different methods in the diagnostic approach of active Graves ophthalmopathy. Clin Nucl Med. 2012;37(11):1097-1101. doi: 10.1097/RLU.0b013e31826c0c16</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Жукова О.Д., Нечеснюк С.Ю. Изменение экстраокулярных мышц у больных эндокринной офтальмопатией. // Вестник офтальмологии. — 2016. — T. 132. — №2. — C. 77-79. [Zhukova OD, Nechesnyuk SY. Extraocular muscles involvement in patients with thyroid-associated ophthalmopathy. Annals of ophthalmology. 2016;132(2):77-79. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Жукова О.Д., Нечеснюк С.Ю. Изменение экстраокулярных мышц у больных эндокринной офтальмопатией. // Вестник офтальмологии. — 2016. — T. 132. — №2. — C. 77-79. [Zhukova OD, Nechesnyuk SY. Extraocular muscles involvement in patients with thyroid-associated ophthalmopathy. Annals of ophthalmology. 2016;132(2):77-79. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Лихванцева В.Г. Харлап С.И., Коростелева Е.В., и др. Гемодинамические нарушения в магистральных сосудах глаза в прогрессировании оптической нейропатии и изменении офтальмотонуса при эндокринной офтальмопатии // Вестник офтальмологии. — 2015. — Т. 131. — №4. — C. 32-37. [Likhvantseva VG, Kharlap SI, Korosteleva EV, et al. Contribution of hemodynamic disturbances in magistral vessels to optic neuropathy progression and ocular tension changes in endocrine ophthalmopathy. Annals of ophthalmology. 2015;131(4):32-37. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Лихванцева В.Г. Харлап С.И., Коростелева Е.В., и др. Гемодинамические нарушения в магистральных сосудах глаза в прогрессировании оптической нейропатии и изменении офтальмотонуса при эндокринной офтальмопатии // Вестник офтальмологии. — 2015. — Т. 131. — №4. — C. 32-37. [Likhvantseva VG, Kharlap SI, Korosteleva EV, et al. Contribution of hemodynamic disturbances in magistral vessels to optic neuropathy progression and ocular tension changes in endocrine ophthalmopathy. Annals of ophthalmology. 2015;131(4):32-37. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Киселева Т.Н., Пантелеева О.Г., Шамшинова А.М. Кровоток в сосудах глаза и орбиты у больных эндокринной офтальмопатией. // Вестник офтальмологии. — 2007. — T. 123. — №1. — C. 33-36. [Kiseleva TN, Panteleeva OG, Shamshinova АМ. Ocular and orbital vascular blood flow in patients with endocrine ophthalmopathy. Annals of ophthalmology. 2007;123(1):33-36. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Киселева Т.Н., Пантелеева О.Г., Шамшинова А.М. Кровоток в сосудах глаза и орбиты у больных эндокринной офтальмопатией. // Вестник офтальмологии. — 2007. — T. 123. — №1. — C. 33-36. [Kiseleva TN, Panteleeva OG, Shamshinova АМ. Ocular and orbital vascular blood flow in patients with endocrine ophthalmopathy. Annals of ophthalmology. 2007;123(1):33-36. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Nik N, Fong A, Derdzakyan M, et al. Changes in Choroidal Perfusion after Orbital Decompression Surgery for Graves' Ophthalmopathy. J Ophthalmic Vis Res. 2017;12(2):183-186. doi: 10.4103/jovr.jovr_165_16</mixed-citation><mixed-citation xml:lang="en">Nik N, Fong A, Derdzakyan M, et al. Changes in Choroidal Perfusion after Orbital Decompression Surgery for Graves' Ophthalmopathy. J Ophthalmic Vis Res. 2017;12(2):183-186. doi: 10.4103/jovr.jovr_165_16</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Walasik-Szemplinska D, Pauk-Domanska M, Sanocka U, Sudol-Szopinska I. Doppler imaging of orbital vessels in the assessment of the activity and severity of thyroid-associated orbitopathy. J Ultrason. 2015;15(63):388-397. doi: 10.15557/JoU.2015.0036</mixed-citation><mixed-citation xml:lang="en">Walasik-Szemplinska D, Pauk-Domanska M, Sanocka U, Sudol-Szopinska I. Doppler imaging of orbital vessels in the assessment of the activity and severity of thyroid-associated orbitopathy. J Ultrason. 2015;15(63):388-397. doi: 10.15557/JoU.2015.0036</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Somer D, Ozkan SB, Ozdemir H, et al. Colour Doppler imaging of superior ophthalmic vein in thyroid-associated eye disease. Jpn J Ophthalmol. 2002;46(3):341-345. doi: 10.1016/s0021-5155(02)00485-9</mixed-citation><mixed-citation xml:lang="en">Somer D, Ozkan SB, Ozdemir H, et al. Colour Doppler imaging of superior ophthalmic vein in thyroid-associated eye disease. Jpn J Ophthalmol. 2002;46(3):341-345. doi: 10.1016/s0021-5155(02)00485-9</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Alp MN. Colour Doppler imaging of the orbital vasculature in Graves' disease with computed tomographic correlation. Br J Ophthalmol. 2000;84(9):1027-1030. doi: 10.1136/bjo.84.9.1027</mixed-citation><mixed-citation xml:lang="en">Alp MN. Colour Doppler imaging of the orbital vasculature in Graves' disease with computed tomographic correlation. Br J Ophthalmol. 2000;84(9):1027-1030. doi: 10.1136/bjo.84.9.1027</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Krieger CC, Neumann S, Place RF, et al. Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by Graves' disease immunoglobins. J Clin Endocrinol Metab. 2015;100(3):1071-1077. doi: 10.1210/jc.2014-3566</mixed-citation><mixed-citation xml:lang="en">Krieger CC, Neumann S, Place RF, et al. Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by Graves' disease immunoglobins. J Clin Endocrinol Metab. 2015;100(3):1071-1077. doi: 10.1210/jc.2014-3566</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Khong JJ, McNab AA, Ebeling PR, et al. Pathogenesis of thyroid eye disease: review and update on molecular mechanisms. Br J Ophthalmol. 2016;100(1):142-150. doi: 10.1136/bjophthalmol-2015-307399</mixed-citation><mixed-citation xml:lang="en">Khong JJ, McNab AA, Ebeling PR, et al. Pathogenesis of thyroid eye disease: review and update on molecular mechanisms. Br J Ophthalmol. 2016;100(1):142-150. doi: 10.1136/bjophthalmol-2015-307399</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Martin CS, Sirbu AE, Betivoiu MA, et al. Serum immunoglobulin G4 levels and Graves' disease phenotype. Endocrine. 2017;55(2):478-484. doi: 10.1007/s12020-016-1157-5</mixed-citation><mixed-citation xml:lang="en">Martin CS, Sirbu AE, Betivoiu MA, et al. Serum immunoglobulin G4 levels and Graves' disease phenotype. Endocrine. 2017;55(2):478-484. doi: 10.1007/s12020-016-1157-5</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao P, Deng Y, Gu P, et al. Insulin-like growth factor 1 promotes the proliferation and adipogenesis of orbital adipose-derived stromal cells in thyroid-associated ophthalmopathy. Exp Eye Res. 2013;107:65-73. doi: 10.1016/j.exer.2012.11.014</mixed-citation><mixed-citation xml:lang="en">Zhao P, Deng Y, Gu P, et al. Insulin-like growth factor 1 promotes the proliferation and adipogenesis of orbital adipose-derived stromal cells in thyroid-associated ophthalmopathy. Exp Eye Res. 2013;107:65-73. doi: 10.1016/j.exer.2012.11.014</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Minich WB, Dehina N, Welsink T, et al. Autoantibodies to the IGF1 receptor in Graves' orbitopathy. J Clin Endocrinol Metab. 2013;98(2):752-760. doi: 10.1210/jc.2012-1771</mixed-citation><mixed-citation xml:lang="en">Minich WB, Dehina N, Welsink T, et al. Autoantibodies to the IGF1 receptor in Graves' orbitopathy. J Clin Endocrinol Metab. 2013;98(2):752-760. doi: 10.1210/jc.2012-1771</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Nowak M, Marek B, Karpe J, et al. Serum concentration of VEGF and PDGF-AA in patients with active thyroid orbitopathy before and after immunosuppressive therapy. Exp Clin Endocrinol Diabetes. 2014;122(10):582-586. doi: 10.1055/s-0034-1383579</mixed-citation><mixed-citation xml:lang="en">Nowak M, Marek B, Karpe J, et al. Serum concentration of VEGF and PDGF-AA in patients with active thyroid orbitopathy before and after immunosuppressive therapy. Exp Clin Endocrinol Diabetes. 2014;122(10):582-586. doi: 10.1055/s-0034-1383579</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Lee JY, Yun M, Paik JS, et al. PDGF-BB Enhances the Proliferation of Cells in Human Orbital Fibroblasts by Suppressing PDCD4 Expression Via Up-Regulation of microRNA-21. Invest Ophthalmol Vis Sci. 2016;57(3):908-913. doi: 10.1167/iovs.15-18157</mixed-citation><mixed-citation xml:lang="en">Lee JY, Yun M, Paik JS, et al. PDGF-BB Enhances the Proliferation of Cells in Human Orbital Fibroblasts by Suppressing PDCD4 Expression Via Up-Regulation of microRNA-21. Invest Ophthalmol Vis Sci. 2016;57(3):908-913. doi: 10.1167/iovs.15-18157</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Virakul S, Dalm VA, Paridaens D, et al. Platelet-Derived Growth Factor-BB Enhances Adipogenesis in Orbital Fibroblasts. Invest Ophthalmol Vis Sci. 2015;56(9):5457-5464. doi: 10.1167/iovs.15-17001</mixed-citation><mixed-citation xml:lang="en">Virakul S, Dalm VA, Paridaens D, et al. Platelet-Derived Growth Factor-BB Enhances Adipogenesis in Orbital Fibroblasts. Invest Ophthalmol Vis Sci. 2015;56(9):5457-5464. doi: 10.1167/iovs.15-17001</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Gianoukakis AG, Khadavi N, Smith TJ. Cytokines, Graves' disease, and thyroid-associated ophthalmopathy. Thyroid. 2008;18(9):953-958. doi: 10.1089/thy.2007.0405</mixed-citation><mixed-citation xml:lang="en">Gianoukakis AG, Khadavi N, Smith TJ. Cytokines, Graves' disease, and thyroid-associated ophthalmopathy. Thyroid. 2008;18(9):953-958. doi: 10.1089/thy.2007.0405</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Роль некоторых про- и противовоспалительных цитокинов в течении эндокринной офтальмопатии. // Забайкальский медицинский вестник. — 2016. — №2. — С. 33-40. [Kharintsev VV, Serebryakova OV, Serkin DM, et al. Rol' nekotorykh pro- i protivovospalitel'nykh tsitokinov v techenii endokrinnoy oftal'mopatii. Zabaykal'skiy meditsinskiy vestnik. 2016;(2):33-40. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Роль некоторых про- и противовоспалительных цитокинов в течении эндокринной офтальмопатии. // Забайкальский медицинский вестник. — 2016. — №2. — С. 33-40. [Kharintsev VV, Serebryakova OV, Serkin DM, et al. Rol' nekotorykh pro- i protivovospalitel'nykh tsitokinov v techenii endokrinnoy oftal'mopatii. Zabaykal'skiy meditsinskiy vestnik. 2016;(2):33-40. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Wong KH, Rong SS, Chong KK, et al. Genetic Associations of Interleukin-related Genes with Graves' Ophthalmopathy: a Systematic Review and Meta-analysis. Sci Rep. 2015;5:16672. doi: 10.1038/srep16672</mixed-citation><mixed-citation xml:lang="en">Wong KH, Rong SS, Chong KK, et al. Genetic Associations of Interleukin-related Genes with Graves' Ophthalmopathy: a Systematic Review and Meta-analysis. Sci Rep. 2015;5:16672. doi: 10.1038/srep16672</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Gillespie EF, Raychaudhuri N, Papageorgiou KI, et al. Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-kappaB. Invest Ophthalmol Vis Sci. 2012;53(12):7746-7753. doi: 10.1167/iovs.12-9861</mixed-citation><mixed-citation xml:lang="en">Gillespie EF, Raychaudhuri N, Papageorgiou KI, et al. Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-kappaB. Invest Ophthalmol Vis Sci. 2012;53(12):7746-7753. doi: 10.1167/iovs.12-9861</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Slowik M, Urbaniak-Kujda D, Bohdanowicz-Pawlak A, et al. CD8+CD28-lymphocytes in peripheral blood and serum concentrations of soluble interleukin 6 receptor are increased in patients with Graves' orbitopathy and correlate with disease activity. Endocr Res. 2012;37(2):89-95. doi: 10.3109/07435800.2011.635622</mixed-citation><mixed-citation xml:lang="en">Slowik M, Urbaniak-Kujda D, Bohdanowicz-Pawlak A, et al. CD8+CD28-lymphocytes in peripheral blood and serum concentrations of soluble interleukin 6 receptor are increased in patients with Graves' orbitopathy and correlate with disease activity. Endocr Res. 2012;37(2):89-95. doi: 10.3109/07435800.2011.635622</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Antonelli A, Ferrari SM, Fallahi P, et al. Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists. J Clin Endocrinol Metab. 2009;94(5):1803-1809. doi: 10.1210/jc.2008-2450</mixed-citation><mixed-citation xml:lang="en">Antonelli A, Ferrari SM, Fallahi P, et al. Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists. J Clin Endocrinol Metab. 2009;94(5):1803-1809. doi: 10.1210/jc.2008-2450</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Fang S, Huang Y, Wang S, et al. IL-17A Exacerbates Fibrosis by Promoting the Proinflammatory and Profibrotic Function of Orbital Fibroblasts in TAO. J Clin Endocrinol Metab. 2016;101(8):2955-2965. doi: 10.1210/jc.2016-1882</mixed-citation><mixed-citation xml:lang="en">Fang S, Huang Y, Wang S, et al. IL-17A Exacerbates Fibrosis by Promoting the Proinflammatory and Profibrotic Function of Orbital Fibroblasts in TAO. J Clin Endocrinol Metab. 2016;101(8):2955-2965. doi: 10.1210/jc.2016-1882</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Wei H, Guan M, Qin Y, et al. Circulating levels of miR-146a and IL-17 are significantly correlated with the clinical activity of Graves' ophthalmopathy. Endocr J. 2014;61(11):1087-1092. doi: 10.1507/endocrj.EJ14-0246</mixed-citation><mixed-citation xml:lang="en">Wei H, Guan M, Qin Y, et al. Circulating levels of miR-146a and IL-17 are significantly correlated with the clinical activity of Graves' ophthalmopathy. Endocr J. 2014;61(11):1087-1092. doi: 10.1507/endocrj.EJ14-0246</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Krizova L, Kuchar M, Petrokova H, et al. p19-targeted ABD-derived protein variants inhibit IL-23 binding and exert suppressive control over IL-23-stimulated expansion of primary human IL-17+ T-cells. Autoimmunity. 2017;50(2):102-113. doi: 10.1080/08916934.2016.1272598</mixed-citation><mixed-citation xml:lang="en">Krizova L, Kuchar M, Petrokova H, et al. p19-targeted ABD-derived protein variants inhibit IL-23 binding and exert suppressive control over IL-23-stimulated expansion of primary human IL-17+ T-cells. Autoimmunity. 2017;50(2):102-113. doi: 10.1080/08916934.2016.1272598</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev. 2008;223:87-113. doi: 10.1111/j.1600-065X.2008.00628.x</mixed-citation><mixed-citation xml:lang="en">Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev. 2008;223:87-113. doi: 10.1111/j.1600-065X.2008.00628.x</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Pujol-Borrell R, Gimenez-Barcons M, Marin-Sanchez A, Colobran R. Genetics of Graves' Disease: Special Focus on the Role of TSHR Gene. Horm Metab Res. 2015;47(10):753-766. doi: 10.1055/s-0035-1559646</mixed-citation><mixed-citation xml:lang="en">Pujol-Borrell R, Gimenez-Barcons M, Marin-Sanchez A, Colobran R. Genetics of Graves' Disease: Special Focus on the Role of TSHR Gene. Horm Metab Res. 2015;47(10):753-766. doi: 10.1055/s-0035-1559646</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Серкин Д.М., Серебрякова О.В., Харинцева С.В., и др. Значение сочетаний полиморфизмов PRO12ALA И C1431T PPARγ в формировании эндокринной офтальмопатии. // Забайкальский медицинский вестник. — 2014. — №2. — С. 38-43. [Serkin DM, Serebryakova OV, Kharintseva SV, et al. Znachenie sochetaniy polimorfizmov PRO12ALA I C1431T PPARγ v formirovanii endokrinnoy oftal'mopatii. Zabaykal'skiy meditsinskiy vestnik. 2014;(2):38-43 (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Серкин Д.М., Серебрякова О.В., Харинцева С.В., и др. Значение сочетаний полиморфизмов PRO12ALA И C1431T PPARγ в формировании эндокринной офтальмопатии. // Забайкальский медицинский вестник. — 2014. — №2. — С. 38-43. [Serkin DM, Serebryakova OV, Kharintseva SV, et al. Znachenie sochetaniy polimorfizmov PRO12ALA I C1431T PPARγ v formirovanii endokrinnoy oftal'mopatii. Zabaykal'skiy meditsinskiy vestnik. 2014;(2):38-43 (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Wong KH, Rong SS, Chong KK, et al. Genetic Associations of Interleukin-related Genes with Graves' Ophthalmopathy: a Systematic Review and Meta-analysis. Sci Rep. 2015;5:16672. doi: 10.1038/srep16672</mixed-citation><mixed-citation xml:lang="en">Wong KH, Rong SS, Chong KK, et al. Genetic Associations of Interleukin-related Genes with Graves' Ophthalmopathy: a Systematic Review and Meta-analysis. Sci Rep. 2015;5:16672. doi: 10.1038/srep16672</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
